PRELUDE CAPITAL MANAGEMENT, LLC

Position in SEER — Seer, Inc.

CIK 1387508 NEW YORK, NY

Position in SEER

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$74,007

-$6,608 QoQ

Shares Held

44,052

0.0% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $74,850,722 across 96 Biotechnology names. SEER ranks #71 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	98,849	$11,349,842
2	FOLD	AMICUS THERAPEUTICS, INC.	639,885	$9,252,737
3	PGEN	Precigen, Inc.	1,270,053	$4,915,105
4	APLS	Apellis Pharmaceuticals, Inc.	111,468	$4,484,357
5	ROIV	Roivant Sciences Ltd.	111,593	$3,091,126
6	PRAX	Praxis Precision Medicines, Inc.	9,064	$2,920,330
7	TERN	Terns Pharmaceuticals, Inc.	54,825	$2,890,374
8	COGT	Cogent Biosciences, Inc.	64,222	$2,471,904

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$74,007	44,052	0.0%	Shares	Other	2026-05-15
2025-12-31	$80,615	44,052	-8.1%	Shares	Other	2026-02-17
2025-09-30	$104,023	47,937	-5.3%	Shares	Other	2025-11-14
2025-06-30	$108,328	50,621	+82.1%	Shares	Other	2025-08-14
2024-03-31	$52,810	27,795	+9.9%	Shares	Other	2024-05-15
2023-12-31	$49,072	25,295	0.0%	Shares	Other	2024-02-14
2023-09-30	$55,901	25,295	+1.6%	Shares	Other	2023-11-14
2023-06-30	$106,301	24,895	-0.1%	Shares	Other	2023-08-14
2023-03-31	$96,148	24,909	+226.8%	Shares	Other	2023-06-01
2021-09-30	$263,187	7,622	+1.8%	Shares	Sole	2021-11-15
2021-06-30	$245,489	7,489	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.